OTX-TKI (Axpaxli) offers a novel approach for wet macular degeneration with sustained drug release up to 9 months via a ...
The Prima photovoltaic retinal stimulation microchip shows promise for restoring central vision in patients with foveal ...
A man underwent one of the first "tooth-in-eye" surgeries ever conducted in Canada. Only a few hundred people have had the surgery, worldwide.